Internal Medicine, Hematology & Oncology · El Paso, TX
NPI
1528353075
Since 2011
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
2
Medicare group memberships
Hospitals
4
Hospital affiliations
5005 N Piedras St Fl 10
El Paso, TX, 79920
Phone (915) 742-2585
Groups this clinician bills Medicare through
Medicare paid, 2024
$2.3M
91,178 services
Medicare patients, 2024
346
Average age 75
Drug cost, 2024
$1.4M
762 prescriptions
Company payments, 2025
$226K
From 36 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Clifton P Layman was code J0185 (injection, aprepitant, 1 mg), 7,020 times for 30 patients. In total Clifton P Layman billed 91,178 services in 142 codes, and Medicare paid $2.3M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2017-10-24.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0185 Injection, aprepitant, 1 mg | Office | 7,020 | 30 | $1.35 | $9,470 |
| J9144 Injection, daratumumab, 10 mg and hyaluronidase-fihj | Office | 4,140 | 14 | $39.23 | $162K |
| J0897 Injection, denosumab, 1 mg | Office | 3,780 | 29 | $20.45 | $77K |
| J2469 Injection, palonosetron hcl, 25 mcg | Office | 1,020 | 46 | $0.67 | $688 |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 960 | 39 | $0.09 | $85.61 |
| J1626 Injection, granisetron hydrochloride, 100 mcg | Office | 580 | 25 | $0.24 | $139 |
| 99215 Office E&M - Established | Office | 552 | 156 | $133.79 | $74K |
| 96375 Injection Administration | Office | 428 | 77 | $11.58 | $4,955 |
| 96413 Chemotherapy Administration | Office | 274 | 97 | $95.20 | $26K |
| J9190 Injection, fluorouracil, 500 mg | Office | 236 | 11 | $2.33 | $549 |
| 96372 Injection Administration | Office | 110 | 69 | $10.96 | $1,206 |
| J9217 Leuprolide acetate (for depot suspension), 7.5 mg | Office | 109 | 25 | $140.42 | $15K |
| 96415 Chemotherapy Administration | Office | 98 | 30 | $20.57 | $2,016 |
| 96402 Chemotherapy Administration | Office | 95 | 38 | $26.67 | $2,534 |
| 96417 Chemotherapy Administration | Office | 84 | 38 | $46.68 | $3,921 |
By year: 2022 $32K for 276 services; 2023 $1.8M for 77,467 services; 2024 $2.3M for 91,178 services.
Medicare prescription drug claims, 2024
In 2024, the drug Clifton P Layman prescribed most often to Medicare patients was Prednisone, with 91 prescriptions and refills. In total Clifton P Layman wrote 762 Medicare prescriptions that cost $1.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Prednisone Generic | 91 | 143 | 30 | $554 |
| Abiraterone Acetate Generic | 50 | 50 | Under 11 | $169K |
| Prochlorperazine Maleate Generic | 38 | 38 | 28 | $568 |
| Anastrozole Generic | 38 | 109 | 16 | $883 |
| Oxycodone Hcl Generic | 33 | 33 | 16 | $754 |
| Potassium Chloride Generic | 28 | 54 | 11 | $380 |
| Pantoprazole Sodium Generic | 26 | 48 | Under 11 | $223 |
| Xtandi Enzalutamide | 23 | 23 | Under 11 | $325K |
| Olanzapine Generic | 21 | 27 | 17 | $272 |
| Dexamethasone Generic | 19 | 27 | 13 | $560 |
| Diphenoxylate-Atropine Diphenoxylate Hcl/Atropine | 15 | 15 | Under 11 | $225 |
| Finasteride Generic | 14 | 30 | Under 11 | $253 |
| Acyclovir Generic | 14 | 15 | Under 11 | $121 |
| Ibrance Palbociclib | 12 | 12 | Under 11 | $193K |
| Tamoxifen Citrate Generic | 11 | 19 | Under 11 | $280 |
Brand drugs: 108 claims; generic drugs: 654 claims; opioid claims: 68.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Clifton P Layman $226K ($226K in general payments such as food, travel and fees) from 36 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $100K.
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP AZN | 77 | $100K |
| Regeneron Healthcare Solutions, Inc. REGN | 48 | $61K |
| E.R. Squibb & Sons, L.L.C. BMY | 33 | $32K |
| Daiichi Sankyo Inc. 4568.T | 18 | $24K |
| Karyopharm Therapeutics Inc. KPTI | 6 | $4,697 |
| Exelixis Inc. EXEL | 15 | $3,234 |
| Novartis Pharmaceuticals Corporation NVS | 24 | $399 |
| Janssen Biotech, Inc. JNJ | 8 | $317 |
| Celgene Corporation BMY | 18 | $211 |
| Abbvie Inc. ABBV | 5 | $138 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.